Influenza B virus B/Brisbane/60/2008 antigen (formaldehyde inactivated)

DB10794ApprovedInvestigationalWithdrawnVaccinesInactivated Influenza B Virus Vaccine

A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection... Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the virus) which stimulates an immunological defence against future exposure to the virus, or "antigen".

First approval
United States, 2009
Also known as
Influenza Virus Vaccine, Inactivated B-Brisbane-60-2008 strain

Resolves to

What you can answer from here — as of April 02, 2025

289Drug interactionsStructured to mechanism, not free text
Sign in
105Clinical trialsPhase, status and sponsor resolved per trial
Sign in
46Marketed productsAcross 3 countries and 7 labellers
Sign in

Which companies are running trials of Influenza B virus B/Brisbane/60/2008 antigen (formaldehyde inactivated), in which indications and phases, and which of those programs are still active?

Create a free account or log in to explore the full data card.

Create Account